comparemela.com

Latest Breaking News On - Steven fruchtman - Page 1 : comparemela.com

Onconova Therapeutics (ONTX) to Merge with Trawsfynydd Therapeutics

Onconova Therapeutics (ONTX) to Merge with Trawsfynydd Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jacke-stover
Torrey-pines
Steven-fruchtman
Mark-guerin-onconova
Mark-guerin
James-marino
Bruce-mackle
C-david-pauza
Snell-wilmer
Werner-cautreels
Robert-redfield

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference

28.11.2023 - NEWTOWN, Pa., Nov. 28, 2023 (GLOBE NEWSWIRE) - Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today .

Bruce-mackle
Mark-guerin
Steven-fruchtman
Lifesci-advisors
Company-contact
Onconova-management-team
Onconova-therapeutics-inc
Breakout-session
Noble-capital-markets
Noble-capital-market
Onconova-therapeutics
Sci-advisors

Onconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCL

Onconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCL
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Spain
United-states
San-diego-convention-center
California
Barcelona
Comunidad-autonoma-de-cataluna
San-diego
American
Nuria-profitos-peleja
Steven-fruchtman
Bruce-mackle-lifesci-advisors
Onconova-therapeutics-inc

Onconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCL Seite 1

02.11.2023 - Preclinical data indicate that narazaciclib shows monotherapy and combination anti-tumor activity in ibrutinib-sensitive and resistant cells and xenograft models NEWTOWN, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) - Onconova Therapeutics, Inc. (NASDAQ: . Seite 1

Spain
Barcelona
Comunidad-autonoma-de-cataluna
Steven-fruchtman
Josep-carreras-leukaemia-research-institute

Onconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCL -November 02, 2023 at 10:38 am EDT

Preclinical data indicate that narazaciclib shows monotherapy and combination anti-tumor activity in ibrutinib-sensitive and resistant cells and xenograft models NEWTOWN, Pa., Nov. 02, 2023 .

Spain
San-diego
California
United-states
San-diego-convention-center
Barcelona
Comunidad-autonoma-de-cataluna
American
Bruce-mackle
Mark-guerin
Nuria-profitos-peleja
Steven-fruchtman

vimarsana © 2020. All Rights Reserved.